104194 Federal Register / Vol. 89, No. 245 / Friday, December 20, 2024 / Notices 

Agenda: Program Updates, Clearance of 

Concepts. 

Address: National Center for Advancing 

Translational Sciences, National Institutes of 

Health, NCI Shady Grove 1E32/1E34, 9609 

Medical Center Drive, Rockville, MD 20850, 

(Virtual Meeting). 

Contact Person: Anna L. Ramsey-Ewing, 

Ph.D.,Executive Secretary, National Center 

for Advancing Translational Sciences, 9609 

Medical Center Drive, Room 1E454, 

Rockville, MD 20850, anna.ramseyewing@

nih.gov, (301) 435–0809. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice no later than 15 days after the 

meeting at NCATSCouncilInput@

mail.nih.gov. The statement should include 

the name, address, telephone number and 

when applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors attending a meeting on 

campus or at an off-campus federal facility 

will be asked to show one form of 

identification (for example, a governmentissued photo ID, driver’s license, or passport) 

and to state the purpose of their visit. 

Information is also available on the 

Institute’s/Center’s home page: https://

ncats.nih.gov/advisory/council, where an 

agenda and any additional information for 

the meeting will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.350, B—Cooperative 

Agreements; 93.859, Biomedical Research 

and Research Training, National Institutes of 

Health, HHS) 

Dated: December 16, 2024. 

David W. Freeman, 

Supervisory Program Analyst, Office of 

Federal Advisory Committee Policy. 

[FR Doc. 2024–30325 Filed 12–19–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Dental & 

Craniofacial Research; Notice of 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Advisory Dental 

and Craniofacial Research Council. 

The meeting will be held as a virtual 

meeting and is partially open to the 

public as indicated below. Individuals 

who plan to view the virtual meeting 

and need special assistance to view the 

meeting, such as sign language 

interpretation or other reasonable 

accommodations, should notify Ms. 

Karon Yarborough (karon.yarborough@

nih.gov) or use the Federal Relay, 1– 

800–877–8339, in advance of the 

meeting. The open session will be 

videocast and can be accessed from the 

NIH Videocasting website (http://

videocast.nih.gov/). Registration is not 

required to access the videocast. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Dental and Craniofacial Research Council. 

Date: January 22, 2025. 

Open: 10:00 a.m. to 1:15 p.m. 

Agenda: Report of the Director, NIDCR and 

concept clearances. 

Address: National Institute of Dental & 

Craniofacial Research, 31 Center Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Closed: 1:30 p.m. to 2:30 p.m. 

Agenda: To review and evaluate BSC 

report to council. 

Address: National Institute of Dental & 

Craniofacial Research, 31 Center Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Closed: 2:30 p.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institute of Dental & 

Craniofacial Research, 31 Center Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Yasaman Shirazi, Ph.D., 

Branch Chief, National Institute of Dental & 

Craniofacial Research, National Institutes of 

Health, 31 Center Drive, Bethesda, MD 

20892, 301–594–5593, Email: 

yasaman.shirazi@nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: https://

www.nidcr.nih.gov/about-us/advisorycommittees/advisory-council, where an 

agenda and any additional information for 

the meeting will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.121, Oral Diseases and 

Disorders Research, National Institutes of 

Health, HHS) 

Dated: December 17, 2024. 

Bruce A. George, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–30446 Filed 12–19–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Secretary; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Interagency Autism 

Coordinating Committee. 

The meeting will be virtually held 

and is open to public viewing. The 

connection information and how to 

access the meeting will be available on 

the IACC website https://iacc.hhs.gov/ 

meetings/iacc-meetings/2025/summaryof-advances/january14/. Advanced 

registration is recommended. 

Individuals wishing to participate 

virtually that need special assistance or 

other reasonable accommodations 

should submit a request to the Contact 

Person listed on this notice at least 

seven (7) business days prior to the 

meeting. 

The purpose of the IACC meeting is 

to discuss the committee’s nominations 

of articles for the 2024 IACC Summary 

of Advances in Autism Research report. 

The final report will summarize the top 

20 advances in autism biomedical and 

services research, as selected by the 

IACC. 

Name of Committee: Interagency Autism 

Coordinating Committee 2024 IACC 

Summary of Advances in Autism Research. 

Date: January 14, 2025. 

Time: 2:00 p.m. to 4:00 p.m. 

Agenda: To discuss the committee’s 

nominations of articles for the 2024 IACC 

Summary of Advances in Autism Research 

report. 

Address: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852. 

Meeting Format: Virtual Meeting. 

Cost: The meeting is free and open to the 

public. 

Registration: A registration web link will 

be posted on the IACC website 

(www.iacc.hhs.gov) prior to the meeting. Preregistration is recommended. 

Contact Person: Ms. Rebecca Martin, Office 

of National Autism Coordination, National 

Institute of Mental Health, NIH, Phone: 301– 

435–0886. 

Email: IACCPublicInquiries@

mail.nih.gov. 

Technical issues: If you experience 

any technical problems with the zoom 


ddrumheller on DSK120RN23PROD with NOTICES1
Federal Register / Vol. 89, No. 245 / Friday, December 20, 2024 / Notices 104195 

webcast, please email 

IACCPublicInquiries@mail.nih.gov. 

Disability Accommodations: All IACC 

Full Committee Meetings provide 

Closed Captioning through the Zoom 

platform. Individuals whose full 

participation in the meeting will require 

special accommodations (e.g., sign 

language or interpreting services, etc.) 

must submit a request to the Contact 

Person listed on the notice at least seven 

(7) business days prior to the meeting. 

Such requests should include a detailed 

description of the accommodation 

needed and a way for the IACC to 

contact the requester if more 

information is needed to fill the request. 

Special requests should be made at least 

seven (7) business days prior to the 

meeting; last-minute requests may be 

made but may not be possible to 

accommodate. 

Meeting schedule subject to change. 

More Information 

Information about the IACC is 

available on the website: http://

www.iacc.hhs.gov. 

Any interested person may file 

written comments with the committee 

by forwarding the statement to the 

Contact Person listed on this notice. The 

statement should include the name, 

address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. In 

the interest of security, NIH has 

procedures at https://www.nih.gov/ 

about-nih/visitor-information/campusaccess-security for entrance into oncampus and off-campus facilities. All 

visitor vehicles, including taxicabs, 

hotel, and airport shuttles will be 

inspected before being allowed on 

campus. Visitors attending a meeting on 

campus or at an off-campus federal 

facility will be asked to show one form 

of identification (for example, a 

government-issued photo ID, driver’s 

license, or passport) and to state the 

purpose of their visit. 

Dated: December 16, 2024. 

David W Freeman, 

Supervisory Program Analyst, Office of 

Federal Advisory Committee Policy. 

[FR Doc. 2024–30338 Filed 12–19–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

contract proposals and the discussions 

could disclose confidential trade secrets 

or commercial property such as 

patentable material, and personal 

information concerning individuals 

associated with the grant applications 

and contract proposals, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Diet, Lipid 

Metabolism, and Cancer. 

Date: January 30, 2025. 

Time: 9:30 a.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Cancer Institute at 

Shady Grove 9609 Medical Center Drive, 

Room 7W248, Rockville, Maryland 20850. 

Meeting Format: Virtual Meeting. 

Contact Person: Shree Ram Singh, Ph.D., 

Scientific Review Officer ,Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W248 Rockville, 

Maryland 20850, 240–672–6175, singhshr@

mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SEP–5: NCI 

Clinical and Translational Cancer Research. 

Date: February 12, 2025. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Cancer Institute at 

Shady Grove 9609 Medical Center Drive, 

Room 7W248, Rockville, Maryland 20850. 

Meeting Format: Virtual Meeting. 

Contact Person: Shree Ram Singh, Ph.D., 

Scientific Review Officer ,Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W248 Rockville, 

Maryland 20850, 240–672–6175, singhshr@

mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; RNA 

Modifications Driving Oncogenesis 

(RNAMoDO; U01 Clinical Trial Not 

Allowed). 

Date: February 14, 2025. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications 

Address: National Cancer Institute at 

Shady Grove 9609 Medical Center Drive, 

Room 7W260, Rockville, Maryland 20850. 

Meeting Format: Virtual Meeting. 

Contact Person: Robert F. Gahl, Ph.D., 

Scientific Review Officer, Special Review 

Branch ,Division of Extramural Activities, 

National Cancer Institute, NIH, 9606 Medical 

Center Drive, Room 7W260 Rockville, 

Maryland 20850, 240–276–7869, robert.gahl@

nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Cancer 

Prevention Clinical Trials Network—Sites 

and Data Management. 

Date: February 14, 2025. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Cancer Institute at 

Shady Grove 9609 Medical Center Drive, 

Room 7W108, Rockville, Maryland 20850. 

Meeting Format: Virtual Meeting. 

Contact Person: Clifford W. Schweinfest, 

Ph.D., Scientific Review Officer, Special 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 7W108, 

Rockville, Maryland 20850, 240–276–6343, 

schweinfestcw@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SEP–12: 

NCI Clinical and Translational Cancer 

Research. 

Date: February 14, 2025. 

Time: 10:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Cancer Institute at 

Shady Grove 9609 Medical Center Drive, 

Room 7W244, Rockville, Maryland 20850. 

Meeting Format: Virtual Meeting. 

Contact Person: Amr M. Ghaleb, Ph.D., 

Scientific Review Officer, Research Program 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 7W244, 

Rockville, Maryland 20850, 240–276–6611, 

amr.ghaleb@nih.gov 

Name of Committee: National Cancer 

Institute Initial Review Group; Career 

Development Study Section (J). 

Date: February 19–20, 2025. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Cancer Institute at 

Shady Grove 9609 Medical Center Drive, 

Room 7W624, Rockville, Maryland 20850. 

Meeting Format: Virtual Meeting. 

Contact Person: Tushar Deb, Ph.D., 

Scientific Review Officer, Resources and 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 9609 Medical Center Drive, 

Room 7W624, Rockville, Maryland 20850, 

240–276–6132, tushar.deb@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SBIR 

Concept Award TEP. 

Date: February 21, 2025. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Address: National Cancer Institute at 

Shady Grove 9609 Medical Center Drive, 

Room 7W608, Rockville, Maryland 20850. 

Meeting Format: Virtual Meeting. 

Contact Person: Nadeem Khan, Ph.D., 

Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 9609 Medical Center 

Drive, Room 7W608, Rockville, Maryland 

20850, 240–276–5856, nadeem.khan@

nih.gov. 


ddrumheller on DSK120RN23PROD with NOTICES1